In the realm of pharmaceutical patent litigation, settlement agreements between branded and generic pharmaceutical companies are frequently used to resolve disputes before, during, and after trials in ...

When patients consider joining clinical trials, we often assume their decisions are logical—balancing risks and benefits. In reality, emotions like fear, hope, trust, and personal history play a far ...

On this week's Business of Biotech, Michelle Werner, CEO at Alltrna, talks transfer RNA (tRNA) therapy with host Ben Comer and guest co-host Anna Rose Welch, editorial and community director at ...

Improvements in diagnostics for the early detection of Alzheimer's disease have the potential to transform patient care and ...